Abstract
Over the last decade our understanding of human gut microbiology underwent a tremendous transformation. The limitations of culture-based methods have given way to Next Generation Sequencing techniques, allowing us to understand the microbial gut community in greater depth. The human GI-tract harbours one of the most complex and abundant ecosystems colonized by more than 100 trillion microorganisms, among which Firmicutes and Bacteroidetes are the major phyla. Although stable over long periods, the composition and functions of the microbiome may be influenced by a number of factors including genetics, mode of delivery, age, diet, geographic location and medical treatments. Dysbiosis, changes in microbiome structure, has been linked to inflammatory, functional and metabolic disorders such as IBD, IBS and obesity. However, it is still not clear whether these changes are a contributing factor or a result of the disease. This synopsis provides a chronological overview of the techniques used to study the gut microbiota and the current knowledge with respect to the stability and variability of microbiome composition and functions.
Keywords: 16S rRNA, composition, diversity, gastrointestinal tract, human gut microbiota, metagenomics, microbiome, sequencing.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Structure and Functions of the Gut Microbiome
Volume: 14 Issue: 4
Author(s): Suchita Panda, Francisco Guarner and Chaysavanh Manichanh
Affiliation:
Keywords: 16S rRNA, composition, diversity, gastrointestinal tract, human gut microbiota, metagenomics, microbiome, sequencing.
Abstract: Over the last decade our understanding of human gut microbiology underwent a tremendous transformation. The limitations of culture-based methods have given way to Next Generation Sequencing techniques, allowing us to understand the microbial gut community in greater depth. The human GI-tract harbours one of the most complex and abundant ecosystems colonized by more than 100 trillion microorganisms, among which Firmicutes and Bacteroidetes are the major phyla. Although stable over long periods, the composition and functions of the microbiome may be influenced by a number of factors including genetics, mode of delivery, age, diet, geographic location and medical treatments. Dysbiosis, changes in microbiome structure, has been linked to inflammatory, functional and metabolic disorders such as IBD, IBS and obesity. However, it is still not clear whether these changes are a contributing factor or a result of the disease. This synopsis provides a chronological overview of the techniques used to study the gut microbiota and the current knowledge with respect to the stability and variability of microbiome composition and functions.
Export Options
About this article
Cite this article as:
Panda Suchita, Guarner Francisco and Manichanh Chaysavanh, Structure and Functions of the Gut Microbiome, Endocrine, Metabolic & Immune Disorders - Drug Targets 2014; 14 (4) . https://dx.doi.org/10.2174/1871530314666140714120744
DOI https://dx.doi.org/10.2174/1871530314666140714120744 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Learning from Metabolic Networks: Current Trends and Future Directions for Precision Medicine
Current Medicinal Chemistry Ephedrines and their Acyclic Derivatives
Current Organic Synthesis Ionotropic Glutamate Receptors & CNS Disorders
CNS & Neurological Disorders - Drug Targets Sirtuins Family- Recent Development as a Drug Target for Aging, Metabolism, and Age Related Diseases
Current Drug Targets Graphical Abstracts:
Central Nervous System Agents in Medicinal Chemistry Interaction of NO and VIP in Gastrointestinal Smooth Muscle Relaxation
Current Pharmaceutical Design Ketogenic Diets in the Treatment of Epilepsy
Current Pharmaceutical Design Human Growth Hormone Induced Cholestatic Hepatitis in a Growth Hormone Deficient Patient with Short Stature
Current Drug Safety Invertebrate Models of Kallmann Syndrome: Molecular Pathogenesis and New Disease Genes
Current Genomics Genetics and Mitochondrial Abnormalities in Autism Spectrum Disorders:A Review
Current Genomics The Role of Anti-Inflammatory Drugs in Respiratory Diseases - Pirfenidone, Penicillamine, Chloroquine and Chlorambucil
Current Respiratory Medicine Reviews Breath Tests to Assess Alcoholic Liver Disease
Reviews on Recent Clinical Trials Associative Learning, the Hippocampus, and Nicotine Addiction
Current Drug Abuse Reviews Lipoprotein(a) Management: Pharmacological and Apheretic Treatment
Current Medicinal Chemistry Pharmacological Approaches of Binge Drinking
Current Pharmaceutical Design Amyotrophic Lateral Sclerosis: A Genetic Point of View
Current Molecular Medicine Child Abuse and Neglect and its Psycho-Physical and Social Consequences: A Review of the Literature
Current Pediatric Reviews Pleural Involvement in Systemic Disorders
Current Drug Targets - Inflammation & Allergy Somatic Drugs for Psychiatric Diseases: Aspirin or Simvastatin for Depression?
Current Neuropharmacology Revising Skin Cancers by Means of Epigenetic Markers
Recent Patents on Biomarkers